Andrew Ajello
Sales & Marketing at Novo Nordisk, Inc.
Network origin in Andrew Ajello first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ.
30
| Subsidiary | Biotechnology | 30 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Andrew Ajello via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| NOVO NORDISK A/S | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
| Boys & Girls Club of Trenton & Mercer County | Director/Board Member Corporate Officer/Principal Director/Board Member | ||
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ALK-ABELLÓ A/S | Biotechnology | Director/Board Member Director/Board Member | |
| Steno Diabetes Center A/S | Director/Board Member Director/Board Member | ||
| University of Aarhus | College/University | Graduate Degree Graduate Degree | |
| University of Copenhagen | College/University | Graduate Degree Doctorate Degree | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| RADIUS HEALTH, INC. | Biotechnology | Chief Executive Officer Sales & Marketing | |
| BIOMX INC. | Biotechnology | Director/Board Member Director/Board Member | |
| INCANNEX HEALTHCARE INC. | Medical Specialties | Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| New York Medical College | College/University | Graduate Degree | |
| University of Nebraska | College/University | Undergraduate Degree | |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Biotechnology | General Counsel | |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | General Government | Corporate Officer/Principal | |
| University of Nebraska College of Law | College/University | Graduate Degree | |
Shook, Hardy & Bacon LLP
 Shook, Hardy & Bacon LLP Miscellaneous Commercial ServicesCommercial Services Shook, Hardy & Bacon LLP engages in the provision of legal services. It offers product liability, intellectual property, business litigation, public policy, and employment litigation and policy. The firm serves pharmaceutical and medical device, food, beverages and agribusiness, insurance and reinsurance, energy, and sports industries. The company was founded by Frank P. Sebree in 1889 and is headquartered in Kansas City, MO. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | General Counsel | |
| FULCRUM THERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel | |
| AVENUE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Davita Kidney Care, Inc.
 Davita Kidney Care, Inc. Medical/Nursing ServicesHealth Services DaVita Kidney Care, Inc. is an American healthcare company that provides kidney dialysis services for patients with chronic kidney failure and end-stage renal disease. The private company is based in Denver. The company operates dialysis centers across the United States and in several other countries. | Medical/Nursing Services | Corporate Officer/Principal | |
| Villanova University | College/University | Doctorate Degree | |
| Temple University (Pennsylvania) | College/University | Graduate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ENZYMOTEC LTD. | Biotechnology | Director/Board Member | |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Delaware | College/University | Masters Business Admin | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Towson University | College/University | Undergraduate Degree | |
Novo Nordisk Region Aameo & Latam A/S
 Novo Nordisk Region Aameo & Latam A/S Financial ConglomeratesFinance Novo Nordisk Region International Operations A/S holds ownership interests in companies that operates within investment and financing activities. The firm also invests capital in companies and real estate. The company was founded in January 1, 2002 and is headquartered in Bagsvaerd, Denmark. | Financial Conglomerates | Chairman | |
Novo Nordisk Region Europe A/S
 Novo Nordisk Region Europe A/S Financial ConglomeratesFinance Novo Nordisk Region Europe A/S holds ownership interests in other companies to undertake investment and financing activities. It offers service on an operational basis, including the placement of capital in companies and real estate. The company was founded September 14, 2001 and is headquartered in Bagsvaerd, Denmark. | Financial Conglomerates | Chairman | |
NNE A/S
 NNE A/S Engineering & ConstructionIndustrial Services Part of Novo Nordisk A/S, NNE A/S is a Danish company that supplies systems, consultancy and engineering services. The company is based in Soborg, Denmark. | Engineering & Construction | Chairman | |
Hempel A/S
 Hempel A/S Industrial SpecialtiesProcess Industries Hempel A/S manufactures and supplies decorative paints and antifouling products. It is a coatings supplier for the decorative, protective, marine, container and yacht markets. The company was founded in 1915 and is headquartered in Kongens Lyngby, Denmark. | Industrial Specialties | Director/Board Member | |
Novo Nordisk North America Operations A/S
 Novo Nordisk North America Operations A/S Financial ConglomeratesFinance Novo Nordisk North America Operations A/S is an investment holding Danish company. The company is based in Bagsværd, Denmark. The company was founded in 2011. The CEO is Peter Bøggild. | Financial Conglomerates | Chairman | |
| OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Lehigh University | College/University | Masters Business Admin | |
| Thomas Jefferson University | College/University | Undergraduate Degree | |
| SIRONA BIOCHEM CORP. | Pharmaceuticals: Major | Director/Board Member | |
| Tranzyme Pharma, Inc. (Canada) | Corporate Officer/Principal | ||
Gurnet Point Capital LLC
 Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital LLC (Gurnet Point Capital) is a private equity/venture capital firm founded in 2013 by Fereydoun Firouz. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
| CORIUM INTERNATIONAL INC | Pharmaceuticals: Major | Director/Board Member | |
Tremeau Pharmaceuticals, Inc.
 Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tremeau Pharmaceuticals, Inc. engages in the developing and delivering of non-opioid pain therapies. The firm product includes TRM-201 (rofecoxib). The company was founded by Bradford C. Sippy and Mark H. N. Corrigan in 2016 and is headquartered in Concord, MA. | Pharmaceuticals: Major | Director/Board Member | |
Alladapt Immunotherapeutics, Inc.
 Alladapt Immunotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alladapt Immunotherapeutics, Inc. operates as a biopharmaceutical company developing prescription therapeutics targeting food allergy. The company was founded by Ashley Dombkowski and Kari Nadeau in 2018 and is headquartered in Menlo Park, CA. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| United States | 36 |
| Denmark | 12 |
| Israel | 3 |
| Canada | 3 |
Sectoral
| Health Technology | 26 |
| Consumer Services | 12 |
| Finance | 5 |
| Commercial Services | 3 |
| Government | 2 |
Operational
| Director/Board Member | 76 |
| Corporate Officer/Principal | 67 |
| Independent Dir/Board Member | 20 |
| Undergraduate Degree | 18 |
| Chief Tech/Sci/R&D Officer | 15 |
Most connected contacts
| Insiders | |
|---|---|
| Michal Silverberg | 17 |
| Anne Phillips | 14 |
| Jakob Riis | 14 |
| Martin Hermanus Soeters | 14 |
| David S. Moore | 13 |
| Edward Williams | 13 |
| Jesper Høiland | 13 |
| Karsten Munk Knudsen | 12 |
| Howard Levy | 11 |
| Alan Moses | 11 |
| Curtis Oltmans | 10 |
| Neena Patil | 9 |
| Lars Green | 9 |
| Eddie Li | 8 |
| Stanislav Glezer | 8 |
- Stock Market
- Insiders
- Andrew Ajello
- Company connections
